INNATE PHARMA SA (IPHYF:OTCMKTS)
$0 None (None%)
Analysed INNATE PHARMA SA (IPHYF:OTCMKTS) News Sources
Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial ...
18-09-2025
yahoo.com
Target initiated, Nike upgraded: Wall Street's top analyst calls
18-09-2025
yahoo.com
How the Narrative Around Innate Pharma Is Shifting After Recent Strategic Decisions
20-09-2025
yahoo.com
Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
06-11-2025
yahoo.com
Innate Pharma Receives US FDA Clearance to Begin Phase 3 Trial of Potential Skin Cancer Therapy
10-11-2025
yahoo.com
Mycosis Fungoides Market Set to Expand by 2034 with Advancements in Targeted and Immunotherapy Approaches | DelveInsight
26-11-2025
yahoo.com
Innate Pharma Q4 Earnings Call Highlights
26-03-2026
marketbeat.com
Innate Pharma SA (IPHA) Full Year 2025 Earnings Call Highlights: Strategic Advances and ...
26-03-2026
yahoo.com
How Innate Pharma (ENXTPA:IPH) Story Is Shifting Around 2026 Catalysts And €8 Target
27-03-2026
yahoo.com
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
27-04-2026
yahoo.com
What is the current price of INNATE PHARMA SA (IPHYF:OTCMKTS)?
The current price of INNATE PHARMA SA (IPHYF:OTCMKTS) is $0.
INNATE PHARMA SA (IPHYF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNATE PHARMA SA (IPHYF:OTCMKTS) since the previous trading day is $None.
INNATE PHARMA SA (IPHYF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNATE PHARMA SA (IPHYF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for INNATE PHARMA SA (IPHYF:OTCMKTS)?
The most recent average sentiment score for INNATE PHARMA SA (IPHYF:OTCMKTS) is 49 out of 100.
What is the most recent average sentiment for INNATE PHARMA SA (IPHYF:OTCMKTS)?
The most recent sentiment for INNATE PHARMA SA (IPHYF:OTCMKTS) is .
SEC-8K** Filing Available For INNATE PHARMA SA (IPHYF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.